Distribution Network
Content
Reed Elsevier is to stop hosting arms fairs over ethical concerns about its involvement with the defence industry.
The Anglo-Dutch multinational publishing group made the announcement in the wake of intensified campaigning against its role as organizer of nine large arms trade fairs around the world.
It said it would ‘exit the defence exhibitions sector’, which accounts for 0.5 per cent of its annual £5billion ($10bn) turnover, in response to concerns from non-governmental organizations, investors and writers for its medical and science journals. It will sell the operation as a going concern rather than shut it down, although it has yet to find a buyer.
‘It has become increasingly clear that growing numbers of important customers and authors have very real concerns about our involvement in the defence exhibitions business,’ said Sir Crispin Davis, the group’s chief executive. ‘We’ve listened closely to these concerns and this has led us to conclude that the defence shows are no longer compatible with Reed Elsevier’s position as a leading publisher of scientific, medical, legal and business content.’ The group intends to complete its withdrawal ‘during the second half of 2007’.
Reed Elsevier, which employs 36,000 people worldwide and publishes thousands of journals, books and reference works, organizes more than 430 trade exhibitions but recently encountered trouble over its arms trade events. The UK-based Campaign against Arms Trade (CAAT) said it had found cluster munitions and torture equipment at Reed Elsevier’s 2006 Shot Show in the US, to which ‘human rights abusing regimes’ such as those in Colombia, Saudi Arabia and Sudan were invited.
F&C Asset Management and the Joseph Rowntree Charitable Trust decided to sell millions of pounds’ worth of shares in the company over the issue, and CAAT sent a letter to institutional investors urging them to follow suit.
One of Reed Elsevier’s publications, The Lancet, also published a letter from healthcare specialists criticizing the group’s arms trade involvement.
CAAT welcomed Reed Elsevier’s decision and praised its board ‘for recognizing the concerns of its stakeholders’.
The Anglo-Dutch multinational publishing group made the announcement in the wake of intensified campaigning against its role as organizer of nine large arms trade fairs around the world.
It said it would ‘exit the defence exhibitions sector’, which accounts for 0.5 per cent of its annual £5billion ($10bn) turnover, in response to concerns from non-governmental organizations, investors and writers for its medical and science journals. It will sell the operation as a going concern rather than shut it down, although it has yet to find a buyer.
‘It has become increasingly clear that growing numbers of important customers and authors have very real concerns about our involvement in the defence exhibitions business,’ said Sir Crispin Davis, the group’s chief executive. ‘We’ve listened closely to these concerns and this has led us to conclude that the defence shows are no longer compatible with Reed Elsevier’s position as a leading publisher of scientific, medical, legal and business content.’ The group intends to complete its withdrawal ‘during the second half of 2007’.
Reed Elsevier, which employs 36,000 people worldwide and publishes thousands of journals, books and reference works, organizes more than 430 trade exhibitions but recently encountered trouble over its arms trade events. The UK-based Campaign against Arms Trade (CAAT) said it had found cluster munitions and torture equipment at Reed Elsevier’s 2006 Shot Show in the US, to which ‘human rights abusing regimes’ such as those in Colombia, Saudi Arabia and Sudan were invited.
F&C Asset Management and the Joseph Rowntree Charitable Trust decided to sell millions of pounds’ worth of shares in the company over the issue, and CAAT sent a letter to institutional investors urging them to follow suit.
One of Reed Elsevier’s publications, The Lancet, also published a letter from healthcare specialists criticizing the group’s arms trade involvement.
CAAT welcomed Reed Elsevier’s decision and praised its board ‘for recognizing the concerns of its stakeholders’.
Super Featured
No
Featured
No